In last trading session, Solid Biosciences Inc (NASDAQ:SLDB) saw 1.91 million shares changing hands with its beta currently measuring 2.28. Company’s recent per share price level of $4.81 trading at $0.07 or 1.48% at ring of the bell on the day assigns it a market valuation of $372.85M. That closing price of SLDB’s stock is at a discount of -115.59% from its 52-week high price of $10.37 and is indicating a premium of 49.9% from its 52-week low price of $2.41. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.69 million shares which gives us an average trading volume of 1.62 million if we extend that period to 3-months.
For Solid Biosciences Inc (SLDB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 6 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Upright in the green during last session for gaining 1.48%, in the last five days SLDB remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $4.81 price level, adding 7.5% to its value on the day. Solid Biosciences Inc’s shares saw a change of -27.34% in year-to-date performance and have moved 3.44% in past 5-day. Solid Biosciences Inc (NASDAQ:SLDB) showed a performance of 58.22% in past 30-days. Number of shares sold short was 8.08 million shares which calculate 4.6 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 19 to the stock, which implies a rise of 74.68% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -149.48% in reaching the projected high whereas dropping to the targeted low would mean a loss of -149.48% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 41.25% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 28.86% while estimates for its earnings growth in next 5 years are of 15.42%.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Insiders are in possession of 0.52% of company’s total shares while institution are holding 102.40 percent of that, with stock having share float percentage of 102.93%. Investors also watch the number of corporate investors in a company very closely, which is 102.40% institutions for Solid Biosciences Inc that are currently holding shares of the company. PERCEPTIVE ADVISORS LLC is the top institutional holder at SLDB for having 6.91 million shares of worth $39.16 million. And as of 2024-06-30, it was holding 16.8725 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 4.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.579 of outstanding shares, having a total worth of $24.55 million.
